A daily medication for Parkinson’s symptoms has successfully completed a late-stage clinical trial, offering hope for the ...
The drug significantly reduced the amount of time patients spent struggling with the stiffness, slowness and tremors ...
Researchers have carried out the first single-cell analysis of mitochondrial DNA in a population of brainstem neurons that ...
The novel GPR6 inhibitor met its primary endpoint in the phase 3 ARISE trial, achieving a statistically significant reduction in daily OFF time and demonstrating non-dopaminergic motor and ...
Parkinson’s disease may begin with subtle changes in movement, sleep, digestion or smell. A visible tremor is a familiar sign ...
Steve Gilbert will cross his eighth marathon finish line in Chicago this weekend. Never an athlete his entire life, he told ...
Solengepras 150 mg achieved a statistically significant reduction in daily OFF time, with benefit seen at Week 2Statistically ...
Members of the sandwich generation are often challenged with the cost and concerns of caring for two generations at the same ...
Parkinson’s disease is now the fastest-growing neurodegenerative disease in the world. In the U.S. alone, over 1 million people are living with it. By 2040, it is believed that more than 17 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results